Follow-The-Filings

Security · featured owners

PLX Protalix Biotherapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 exit

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management exited 2026 Q2 last 2026 Q1 0.10% Exit −0.10% 340,000 $738K history

0 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $65.49M $53.4M $52.74M
Gross profit * $42.51M $29.08M $25.75M
Gross margin * 64.9% 54.5% 48.8%
Net income $8.31M $2.93M -$6.6M
Net margin * 12.7% 5.5% -12.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $69.93M $60.08M $66.67M
Total non-current assets * $14.5M $13.34M $15.67M
Total assets $84.43M $73.42M $82.35M
Total current liabilities $45.53M $25.62M $26.52M
Total non-current liabilities $5.34M $4.58M $7.6M
Total equity $33.57M $43.21M $48.23M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.32M $8.67M -$11.99M
Cash from investing -$16.71M $4.22M -$2.37M
Cash from financing $24.67M -$16.79M $9.33M
Net change in cash $6.52M -$3.87M -$5.08M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders